PredictImmune

Cambridge, United Kingdom

Providing tools to physicians in the treatment of patients with immune-mediated disease, through prediction of long term clinical prognosis.

Mar 2023

Grant

Biopharma Biotechnology Health Care Life Science Medical

Top Investors

Parkwalk Advisors Business Growth Fund Wellcome Trust Cambridge Innovation Capital Innovate UK

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about PredictImmune

Who are PredictImmune's investors?

PredictImmune's investors include Parkwalk Advisors, Business Growth Fund, Wellcome Trust, Cambridge Innovation Capital, Innovate UK.

Where is PredictImmune headquartered?

PredictImmune is headquartered in Cambridge, United Kingdom.

What does PredictImmune do?

Providing tools to physicians in the treatment of patients with immune-mediated disease, through prediction of long term clinical prognosis.

What stage is PredictImmune at?

PredictImmune is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 20, 2023.

MLA

"PredictImmune — Funding & Investors." VCBacked, March 20, 2023, https://www.vcbacked.co/company/predictimmune. Accessed July 2, 2026.

APA

VCBacked. (2023). PredictImmune — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/predictimmune

Wikipedia (cite web)

{{cite web |title=PredictImmune — Funding & Investors |url=https://www.vcbacked.co/company/predictimmune |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 20, 2023.

Similar Companies in Biopharma

View all

Allterum Therapeutics

Living In Silico Inc.